T
Trulieve Cannabis Corp
CNSX:TRUL
Trulieve Cannabis Corp
CNSX:TRUL
Price:
9.25
CAD
-5.42%
Market Cap:
CA$1.8B
Relative Value
The Relative Value of one TRUL stock under the Base Case scenario is 12.43 CAD. Compared to the current market price of 9.25 CAD, Trulieve Cannabis Corp is Undervalued by 26%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TRUL
Relative Value
Base Case
12.43
CAD
Undervaluation 26%
T
Multiples Across Competitors
TRUL Competitors Multiples
Trulieve Cannabis Corp Competitors
Trulieve Cannabis Corp Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
T
|
Trulieve Cannabis Corp
CNSX:TRUL
|
1.8B CAD | 1.1 | -9.7 | 5 | 11.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
947.4B USD | 15.9 | 51.3 | 34.5 | 36.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564B USD | 6 | 21 | 14.6 | 17.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.9B GBP | 5.1 | 31.7 | 15.1 | 22.1 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
290.3B USD | 4.5 | 15.2 | 10.7 | 12.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
225.6B CHF | 5.2 | 20.2 | 12.7 | 16.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.6T DKK | 5.2 | 15.9 | 11 | 12.8 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
145.7B USD | 2.3 | 14.9 | 7.6 | 10.3 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
